Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
DelMar Pharmaceuticals announced the closing of a $9 million offering of common stock and warrants which was led by leading healthcare dedicated institutional investors.
read more
DelMar Pharmaceuticals has announced the appointments of three additional neuro-oncologists to its Scientific Advisory Board (SAB).
read more
Wednesday, October 16, 2019
Delpharm and Famar have entered into exclusive negotiations for the acquisition by Delpharm of five Famar manufacturing sites in France, the Netherlands and Canada.
read more
Delpharm announced that it has reached an agreement with the Government of Canada to modernize its injectable manufacturing facility in Boucherville.
read more
Dendreon Pharmaceuticals, a commercial-stage biopharmaceutical company and pioneer in the development of cellular immunotherapy, announced the appointment of Sherry Saurini as Vice President of Quality, effective August 23, 2021. Saurini will focus ...
read more
Wednesday, November 17, 2021
Flagship Facility Services has announced the finalization of a partnership with DENS Facility Services (DENS), headquartered in Greater Boston and a leader in providing Life Sciences laboratory support and facility maintenance services to that ...
read more
The contract provides partial funding for ongoing development of ARX-04, including Phase 3 clinical, manufacturing and regulatory activities.
read more
Wednesday, January 15, 2020
Dermavant Sciences has entered into a collaboration and license agreement with Japan Tobacco for exclusive rights to develop, register and market tapinarof in Japan for psoriasis and atopic dermatitis.
read more
Wednesday, August 15, 2018
Desert Oasis Healthcare and Proteus Digital Health announced a multi-year collaboration established with a value-based contract.
read more
Wednesday, March 25, 2020
Destiny Pharma announced the completion of the initial phase of its project with MedPharm to develop new topical formulations of the Company’s novel XF-platform drugs.
read more
Wednesday, August 19, 2020
BEKHealth and Devana Solutions have finalized an agreement to integrate their platforms.
read more
Devonian and Histapharm announced they have signed a binding LOI to negotiate the terms establishing Devonian as the exclusive site for manufacturing of Histapharm’s proprietary botanical drug.
read more
Wednesday, September 13, 2023
Devyser and Thermo Fisher Scientific entered an agreement to promote laboratory services. The goal is to partner with pharmaceutical companies to support their development projects utilising Devyser's unique assays in its CLIA-certified laboratory.
read more
AI VIVO has announced its platform correctly identified dexamethasone as having high potential for the treatment of COVID-19 in April 2020.
read more
DFE Pharma, a global leader in pharma-, biopharma-and nutraceutical excipient solutions, has appointed Marie-Louise Mans as Global Human Resources (HR) Director, joining as a member of the Leadership Team. DFE Pharma, headquartered in Goch, Germany, ...
read more